Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

More protein tyrosine kinase inhibitors in the pipeline at Glaxo Wellcome

April 7, 1998

New U.S. patent provides further protection for Onconase and related products

April 6, 1998

Protein tyrosine kinase inhibitors emerge from R&D at Glaxo Wellcome

April 6, 1998

TER-199 resistance-modulating mechanisms explored

April 6, 1998

CGP-60474: selective protein tyrosine kinase inhibitor for cancer

April 3, 1998

Abbott/TAP discover safer LHRH antagonists

April 3, 1998

Stehlin Foundation describes new camptothecins with improved stability

April 3, 1998

New prenyl transferase inhibitors in development at BMS

April 3, 1998

Neovastat efficacy reported at AACR

April 3, 1998

Genetix cancer gene therapy approach gives promising results in preliminary studies

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...